Dave Garman, PhDChief Technology Officer at NoNO, Inc.Speaker
Profile
Dr. Garman has been with NoNO Inc since 2010 and is currently the Chief Technology Officer, responsible for discovery, preclinical development, manufacturing and intellectual property. Dr. Garman has over 35 years of experience in laboratory science and has spent more than 20 years in biotechnology, holding various positions encompassing discovery and translational research, quality assurance, manufacturing, intellectual property and business development. For the past 13 years, Dr. Garman has been focused on the development of neurotherapeutics for the treatment of stroke and related indications and translation of those compounds to the clinic, including the development of clinical and commercial manufacturing processes and controls. Dr. Garman received his PhD in Developmental Biology from Stanford University.
Agenda Sessions
Peptide Validation Strategy to Support Commercial Manufacturing and Distribution
, 16:30View Session